5-Nov-2025 3:22 PM CST - Business Wire Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance Phibro Animal Health Corporation (Nasdaq: PAHC) (Phibro or the Company) today announced financial results for its first quarter ended September 30, 2025 and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended September 30, 2025 (compared to the three months ended September 30, 2024) Net sales of $363.9 million, an increase of $103.5 million, or 40% Net income of $26.5 million, an increase of $19.6 million Di
4-Nov-2025 3:10 PM CST - Business Wire Phibro Animal Health Corporation Declares Quarterly Dividend The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 17, 2025, to stockholders of record at the close of business on November 26, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner w
29-Oct-2025 3:00 PM CST - Business Wire Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 5, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 6, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (88
2-Sep-2025 3:00 PM CST - Business Wire Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. Chief Financial Officer, Glenn David will address financial analysts and investors on Tuesday, September 9, 2025, at 12:20 PM ET at the Sheraton New York Times Square Hotel. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com. A repl
27-Aug-2025 3:57 PM CST - Business Wire Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance Phibro Animal Health Corporation (Nasdaq: PAHC) (Phibro or the Company) today announced financial results for its fourth quarter and fiscal year ended June 30, 2025 and provided its financial guidance for the year ending June 30, 2026. Highlights for the three months ended June 30, 2025 (compared to the three months ended June 30, 2024) Net sales of $378.7 million, an increase of $105.5 million, or 39% Net income of $17.2 million, an increase of $16.5 million
20-Aug-2025 3:00 PM CST - Business Wire Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2025 Results Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2025 financial results on Wednesday, August 27, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 28, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be availab
29-Jul-2025 3:10 PM CST - Business Wire Phibro Animal Health Corporation Declares Quarterly Dividend The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 24, 2025, to stockholders of record at the close of business on September 3, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner
22-May-2025 3:00 PM CST - Business Wire Phibro Animal Health Corporation to Participate at Stifel Jaws & Paws Conference Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws & Paws Conference. Chief Operating Officer, Larry Miller along with Director and Executive Vice President, Corporate Strategy, Daniel Bendheim will address financial analysts and investors on Thursday, May 29, 2025, at 8:35 AM ET at the Lotte New York Hotel in New York. The live audio presentation will be available on the Phibro Animal Health Corporation Inv
7-May-2025 3:30 PM CST - Business Wire Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance Phibro Animal Health Corporation (Nasdaq: PAHC) (Phibro or the Company) today announced financial results for its third quarter ended March 31, 2025, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended March 31, 2025 (compared to the three months ended March 31, 2024) Net sales of $347.8 million, an increase of $84.6 million, or 32% Net income of $20.9 million, an increase of $12.5 million Diluted earnin
5-Nov-2025 3:22 PM CST - Business Wire Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance Phibro Animal Health Corporation (Nasdaq: PAHC) (Phibro or the Company) today announced financial results for its first quarter ended September 30, 2025 and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended September 30, 2025 (compared to the three months ended September 30, 2024) Net sales of $363.9 million, an increase of $103.5 million, or 40% Net income of $26.5 million, an increase of $19.6 million Di
4-Nov-2025 3:10 PM CST - Business Wire Phibro Animal Health Corporation Declares Quarterly Dividend The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 17, 2025, to stockholders of record at the close of business on November 26, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner w
29-Oct-2025 3:00 PM CST - Business Wire Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 5, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 6, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (88
2-Sep-2025 3:00 PM CST - Business Wire Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. Chief Financial Officer, Glenn David will address financial analysts and investors on Tuesday, September 9, 2025, at 12:20 PM ET at the Sheraton New York Times Square Hotel. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com. A repl
27-Aug-2025 3:57 PM CST - Business Wire Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance Phibro Animal Health Corporation (Nasdaq: PAHC) (Phibro or the Company) today announced financial results for its fourth quarter and fiscal year ended June 30, 2025 and provided its financial guidance for the year ending June 30, 2026. Highlights for the three months ended June 30, 2025 (compared to the three months ended June 30, 2024) Net sales of $378.7 million, an increase of $105.5 million, or 39% Net income of $17.2 million, an increase of $16.5 million
20-Aug-2025 3:00 PM CST - Business Wire Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2025 Results Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2025 financial results on Wednesday, August 27, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 28, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be availab
29-Jul-2025 3:10 PM CST - Business Wire Phibro Animal Health Corporation Declares Quarterly Dividend The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 24, 2025, to stockholders of record at the close of business on September 3, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner
22-May-2025 3:00 PM CST - Business Wire Phibro Animal Health Corporation to Participate at Stifel Jaws & Paws Conference Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws & Paws Conference. Chief Operating Officer, Larry Miller along with Director and Executive Vice President, Corporate Strategy, Daniel Bendheim will address financial analysts and investors on Thursday, May 29, 2025, at 8:35 AM ET at the Lotte New York Hotel in New York. The live audio presentation will be available on the Phibro Animal Health Corporation Inv
7-May-2025 3:30 PM CST - Business Wire Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance Phibro Animal Health Corporation (Nasdaq: PAHC) (Phibro or the Company) today announced financial results for its third quarter ended March 31, 2025, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended March 31, 2025 (compared to the three months ended March 31, 2024) Net sales of $347.8 million, an increase of $84.6 million, or 32% Net income of $20.9 million, an increase of $12.5 million Diluted earnin
